Bletilla striata Polysaccharide Stimulates Inducible Nitric Oxide Synthase and Proinflammatory Cytokine Expression in Macrophages

Journal of Bioscience and Bioengineering

Volumn 105, Issue 2, 2008, Pages 85-89

  Diao, Huajia ^a   Li, Xin ^a   Chen, Jiangning ^a   Luo, Yi ^a   Chen, Xi ^a   Dong, Lei ^a   Wang, Chunming ^a   Zhang, Chenyu ^a   Zhang, Junfeng ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Bletilla striata polysaccharide; inducible nitric oxide synthase; interferon gamma (IFN ); interleukin 1 beta (IL 1 ); nitric oxide; tumor necrosis factor alpha (TNF )

Indexed keywords

CYTOKINES; NITRIC OXIDE SYNTHASE; VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF);

CELL PROLIFERATION; ENZYMES; GROWTH KINETICS; MACROPHAGES; NITRIC OXIDE;

POLYSACCHARIDES;

BLETILLA STRIATA EXTRACT; CYTOKINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MESSENGER RNA; PLANT EXTRACT; POLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLETILLA STRIATA; CHINESE MEDICINE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; DRUG SYNTHESIS; ENZYME ACTIVATION; GENE EXPRESSION; MACROPHAGE; MEDICINAL PLANT; MOUSE; NONHUMAN; WOUND HEALING;

ANIMALS; CELL LINE; CYTOKINES; DRUGS, CHINESE HERBAL; GENE EXPRESSION; IMMUNOLOGIC FACTORS; MACROPHAGES; MICE; NITRIC OXIDE SYNTHASE TYPE II; ORCHIDACEAE; POLYSACCHARIDES; WOUND HEALING;

BLETILLA STRIATA;

EID: 40749147144     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1263/jbb.105.85     Document Type: Article

References (31)

1. Wang C., Sun J., Luo Y., Xue W., Diao H., Dong L., Chen J., and Zhang J. A polysaccharide isolated from the medicinal herb Bletilla striata induces endothelial cells proliferation and vascular endothelial growth factor expression in vitro. Biotechnol. Lett. 28 (2006) 539-543
2. Schwentker A., Vodovotz Y., Weller R., and Billiar T. Nitric oxide and wound repair: role of cytokines?. Nitric Oxide 7 (2002) 1-10
3. Frank J., Born K., Barker J., and Marzi I. In vivo effect of tumor necrosis factor alpha onwound angiogenesis and epithelialization. Eur. J. Trauma 29 (2003) 208-219
4. Liu X., Fan X., Zhao Y., Luo G., Li X., Li R., and Le W. Estrogen proviedes neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-α and estrogen receptor-β in microgila. J. Neurosci. Res. 81 (2005) 653-665
5. Schmittgen T., Zakrajsek B., Mills A., Gorn W., Singer M., and Reed M. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal. Biochem. 285 (2000) 194-204
6. Albina J., Mills C., Henry W., and Caldwell M. Temporal expression of different pathways of l-arginine metabolism in healing wounds. Immunology 144 (1990) 3877-3880
7. Lee R.-H., Efron D., Tantry U., and Barbul A. Nitric oxide in the healing wound: a time-course study. J. Surg. Res. 101 (2001) 104-108
8. Cals-Grierson M., and Ormerod A. Nitric oxide function in the skin. Nitric Oxide 10 (2004) 179-193
9. Krischel V., Bruch-Gerharz D., and Suschek C. Biphasic effect of exogenous nitric oxide on proliferation and differentiation in skin derived keratinocytes but not fibroblasts. J. Invest. Dermatol. 111 (1998) 286-291
10. Ignarro L. Biosynthesis and metabolism of endotheliumderived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30 (1990) 535-560
11. Moncada S., Palmer R., and Higgs E. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43 (1991) 109-142
12. Wu H., Huang Q., Yuan Y., and Granger H. VEGF induces NO-dependent hyperpermeability in coronary venules. Am. J. Physiol. 271 (1996) H2735-H2739
13. Hübner G., Brauchle M., Smola H., Madlener M., Fassler R., and Werner S. Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine 8 (1996) 548-556
14. Piguet P., Grau G., and Vassalli J. Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillars and epidermal cells, or massive tissue necrosis. Am. J. Pathol. 136 (1990) 103-110
15. Mauviel A., Daireaux M., Redini F., Galera P., Loyau G., and Pujoi J.-P. Tumor necrosis factor inhibits collagen and fibronectin synthesis in human dermal fibroblasts. FEBS Lett. 236 (1988) 47-52
16. Solis H., Brenner D., and Chojkier M. Tumor necrosis factor alpha inhibits collagen gene transcription and collagen synthesis in cultured human fibroblasts. J. Biol. Chem. 263 (1988) 5841-5845
17. Roesel J., and Nanney L. Assessment of differential cytokine effects on angiogenesis using an in vivo model of cutaneous wound repair. J. Surg. Res. 58 (1995) 449-459
18. Fràter-Schröder M., Risau W., Hallmann R., Gautschi P., and Böhlen P. Tumor necrosis factor type α, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc. Natl. Acad. Sci. USA 84 (1987) 5277-5281
19. Lechner M., Lirk P., and Rieder J. Inducible nitric oxide synthase (iNOS) in tumor biology-The two sides of the same coin. Semin. Cancer. Biol. 15 (2005) 277-289
20. Coleman J. Nitric oxide in immunity and inflammation. Int. Immunopharmacol. 1 (2001) 1397-1406
21. Geller D., de Vera M., Russell D., Shapiro R., Nussler A., Simmons R., and Billiar T. A central role for IL-1 beta in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase. IL-1 beta induces hepatic nitric oxide synthesis. J. Immunol. 155 (1995) 4890-4898
22. Magrinat G., Mason S., Shami P., and Weinberg J. Nitric oxide modulation of human leukemia cell differentiation and gene expression. Blood 80 (1992) 1880-1884
23. Eigler A., Sinha B., and Endres S. Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells. Biochem. Biophys. Res. Commun. 196 (1993) 494-501
24. Eigler A., Moeller J., and Endres S. Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW264.7. J. Immunol. 154 (1995) 4048-4054
25. Lander H., Sehajpal P., Levine D., and Novogrodsky A. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 150 (1993) 1509-1516
26. Deakin A., Payne A., Whittle B., and Moneada S. The modulation of IL-6 and TNF-α release by nitric oxide following stimulation of J774 cells with LPS and IFN-7. Cytokine 7 (1995) 408-416
27. Marcinkiewicz J., Grabowska A., and Chain B. Nitric oxide upregulates the release of inflammatory mediators by mouse macrophages. Eur. J. Immunol. 25 (1995) 947-951
28. Zinetti M., Fantuzzi G., Delgado R., Di Santo E., Ghezzi P., and Fratelli M. Endogenous nitric oxide production by human monocytic cells regulates LPS-induced TNF production. Eur. Cytokine Netw. 6 (1995) 45-48
29. Jiang W. Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. Trends Pharmacol. Sci. 26 (2005) 558-563
30. Yancopoulos G., Davis S., Gale N., Rudge J., Wlegand S., and Holash J. Vascular-specific growth factors and blood vessel formation. Nature 407 (2000) 242-248
31. Jacobi J., Tam B., Sundram U., Blau H., Kuo C., and Cooke J. Discordant effects of a soluble VEGF receptor on wound healing and angiogenesis. Gene Ther. 11 (2004) 302-309